Attached files

file filename
10-K - 10-K - Cardiovascular Systems Inccsii10-kx63018.htm
EX-32.2 - EXHIBIT 32.2 - Cardiovascular Systems Incex322-63018.htm
EX-32.1 - EXHIBIT 32.1 - Cardiovascular Systems Incex321-63018.htm
EX-31.2 - EXHIBIT 31.2 - Cardiovascular Systems Incex312-63018.htm
EX-31.1 - EXHIBIT 31.1 - Cardiovascular Systems Incex311-63018.htm
EX-23.1 - EXHIBIT 23.1 - Cardiovascular Systems Incex231-63018.htm
EX-10.57 - EXHIBIT 10.57 - Cardiovascular Systems Incex1057-secondleaseamendmen.htm
EX-10.26 - EXHIBIT 10.26 - Cardiovascular Systems Incex1026-executiveseverancep.htm
EX-10.6 - EXHIBIT 10.6 - Cardiovascular Systems Incex106fy19directorcompensatio.htm
EX-10.5 - EXHIBIT 10.5 - Cardiovascular Systems Incex105-fy19execincentiveplan.htm


Exhibit 10.4

FISCAL YEAR 2019 EXECUTIVE OFFICER BASE SALARIES
The Company’s executive officers are scheduled to receive the following annual base salaries for the fiscal year ending June 30, 2019 in their current positions:
Name/Title
  
FY2019 Salary
 
Scott R. Ward
Chairman, President and Chief Executive Officer
  
 
$
670,000

  
Jeffrey S. Points
Chief Financial Officer
  
 
$
302,500

  
Rhonda J. Robb
Chief Operating Officer
 
 
$
463,500

 
Laura J. Gillund
Chief Talent Officer
 
 
$
315,655

  
Alexander Rosenstein
General Counsel and Corporate Secretary
  
 
$
317,623

 
Sandra M. Sedo
Chief Compliance Officer
 
 
$
283,608